Company intelligence / Profile preview

Medfield Diagnostics

Gothenburg, Swedenmedfielddiagnostics.com ↗

Ownership: Private
Development stage: Other

Overview

Medfield Diagnostics has developed the Strokefinder MD100 device for rapid pre-hospital screening and triage of suspected intracranial injuries using microwave technology. The system aims to support faster diagnosis and treatment decisions in acute care settings. Clinical studies have demonstrated its potential to distinguish between different types of brain injuries. No traditional drug clinical trial results as it’s a medical device.

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapy (microwave-based diagnostic device)
Industry: Medical Imaging

Partnerships

Collaborations with Chalmers University of Technology for research & development

Beyond the preview

Go deeper on Medfield Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medfield Diagnostics.

Explore the full profile